BioAtla BCAB
OTC BCAB
$1.45 +0.12 (+9.02%)
As of: Oct 21, 2026 · 12:24 PM EDT

BioAtla (BCAB) Other financing activities (2025 - 2026)

Updated

BioAtla's Other financing activities came in at $289,000 for Q1 2026, down 21.0% from $366,000 a year earlier and down 36.2% from the prior quarter.

Analysis

BioAtla (BCAB) Other financing activities (2025 - 2026) Analysis & Trends

For FY2025, BioAtla's Other financing activities was $897,000.

  • Other financing activities carries a five-year compound annual growth rate of 116.2% (FY2020 to FY2025).
  • The five-year range for quarterly Other financing activities is $78,000 (Q2 2025) to $453,000 (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 BioAtla 2.41 Mn -16.54 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 -289,000.00
Dec 31, 2025 -453,000.00
Jun 30, 2025 -78,000.00
Mar 31, 2025 -366,000.00
API Access

BioAtla Other financing activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-financing-activities&ticker=BCAB&period=max&api_key=YOUR_API_KEY